Ankeet Bhatt MD, Leandro Boer MD, Gemme Campbell-Salome PhD, Erica Davis, Nihar Desai MD, Jyothis George MD, Ty Gluckman MD, Lisa Head PharmD, Francoise Marvel MD, Marc Penn MD, Eric Peterson MD, Nishant Shah MD, Katherine Wilemon, Bethany Kalich PharmD, Seth Martin MD, Laney Jones PharmD
{"title":"Accelerating evidence generation to implementation in cardiometabolic health: Establishment of the LATTICE Consortium","authors":"Ankeet Bhatt MD, Leandro Boer MD, Gemme Campbell-Salome PhD, Erica Davis, Nihar Desai MD, Jyothis George MD, Ty Gluckman MD, Lisa Head PharmD, Francoise Marvel MD, Marc Penn MD, Eric Peterson MD, Nishant Shah MD, Katherine Wilemon, Bethany Kalich PharmD, Seth Martin MD, Laney Jones PharmD","doi":"10.1016/j.jacl.2025.04.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Synopsis</h3><div>Recent scientific advancements have led to the development of innovative therapies to reduce the risk of cardiometabolic events, offering new hope to address the world's leading cause of mortality. However, the time from evidence generation in the research-setting to implementation in the care-setting is elongated, has resulted in a high rate of cardiovascular and metabolic consequences for patients, clinicians, and health systems in the United States.</div></div><div><h3>Objective/Purpose</h3><div>Improved collaboration among patients, clinicians, health systems, payers, patient advocacy, and life science companies to translate evidence-based advancements into clinical practice is key to closing this health care gap.</div></div><div><h3>Methods</h3><div>Utilizing implementation science theories, methods, and frameworks can improve translation of evidence-based practices to improve cardiometabolic care. To close the gaps in cardiometabolic care, we will evaluate implementation tools, methodologies, and strategies. We will then measure both implementation and health outcomes.</div></div><div><h3>Results</h3><div>We describe the establishment of the LATTICE consortium, Leading Awareness to Action through Implementation of Cardiometabolic Efforts. LATTICE is a first-of-its-kind community dedicated to addressing cardiometabolic patient needs through implementation efforts (Figure). The LATTICE consortium helps unite partners contributing to the overall mission of improving cardiometabolic health by creating an inclusive platform for sharing evidence-based tools, methodologies, and strategies and collaborating to improve the effectiveness of cardiometabolic patient care at scale.</div></div><div><h3>Conclusions</h3><div>Success of LATTICE consortium will be measured by reducing time from evidence generation to implementation, improved awareness, and downstream implementation by individuals of successful, scalable, and sustainable care strategies that close cardiometabolic care gaps in meaningful ways.</div></div>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":"19 3","pages":"Pages e5-e6"},"PeriodicalIF":3.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1933287425000844","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background/Synopsis
Recent scientific advancements have led to the development of innovative therapies to reduce the risk of cardiometabolic events, offering new hope to address the world's leading cause of mortality. However, the time from evidence generation in the research-setting to implementation in the care-setting is elongated, has resulted in a high rate of cardiovascular and metabolic consequences for patients, clinicians, and health systems in the United States.
Objective/Purpose
Improved collaboration among patients, clinicians, health systems, payers, patient advocacy, and life science companies to translate evidence-based advancements into clinical practice is key to closing this health care gap.
Methods
Utilizing implementation science theories, methods, and frameworks can improve translation of evidence-based practices to improve cardiometabolic care. To close the gaps in cardiometabolic care, we will evaluate implementation tools, methodologies, and strategies. We will then measure both implementation and health outcomes.
Results
We describe the establishment of the LATTICE consortium, Leading Awareness to Action through Implementation of Cardiometabolic Efforts. LATTICE is a first-of-its-kind community dedicated to addressing cardiometabolic patient needs through implementation efforts (Figure). The LATTICE consortium helps unite partners contributing to the overall mission of improving cardiometabolic health by creating an inclusive platform for sharing evidence-based tools, methodologies, and strategies and collaborating to improve the effectiveness of cardiometabolic patient care at scale.
Conclusions
Success of LATTICE consortium will be measured by reducing time from evidence generation to implementation, improved awareness, and downstream implementation by individuals of successful, scalable, and sustainable care strategies that close cardiometabolic care gaps in meaningful ways.
期刊介绍:
Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner.
Sections of Journal of clinical lipidology will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.